Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

Technology appraisal guidance
Reference number: TA209
Published: 24 November 2010

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): final scrutiny letter

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): final scrutiny letter

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): final scrutiny letter
24 November 2010
(18.32 Kb 5 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 24 November 2010